Benefit of Heparin Plus Aspirin vs Aspirin Alone in Unstable Angina

JAMA: The Journal of the American Medical Association

Volumn 276, Issue 23, 1996, Pages 1873-

  Collins, Rory ^a   Peto, Richard ^b  

^a MSc ^*  (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; HUMAN; LETTER; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS; BLEEDING; HEART INFARCTION; NOTE;

ANGINA, UNSTABLE; ASPIRIN; HEMORRHAGE; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; META-ANALYSIS;

EID: 0029955916     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1996.03540230023014     Document Type: Letter

References (4)

1. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a metaanalysis. JAMA. 1996;276:811-815.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
3. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med. In press.
4. Collins R, MacMahon S, Flather M, et al. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomized trials. BMJ. 1996;313:652-659.